Cargando…

Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness

BACKGROUND: The Discoidin Domain Receptor 1 (DDR1) is one of the two members of a unique family of receptor tyrosine kinase receptors that signal in response to collagen, which has been implicated in cancer progression. Here, we examined the expression of DDR1 in prostate cancer (PCa), and assessed...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonfil, R. Daniel, Chen, Wei, Vranic, Semir, Sohail, Anjum, Shi, Dongping, Jang, Hyejeong, Kim, Hyeong-Reh, Prunotto, Marco, Fridman, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456559/
https://www.ncbi.nlm.nih.gov/pubmed/34548097
http://dx.doi.org/10.1186/s12935-021-02206-1
_version_ 1784570890749476864
author Bonfil, R. Daniel
Chen, Wei
Vranic, Semir
Sohail, Anjum
Shi, Dongping
Jang, Hyejeong
Kim, Hyeong-Reh
Prunotto, Marco
Fridman, Rafael
author_facet Bonfil, R. Daniel
Chen, Wei
Vranic, Semir
Sohail, Anjum
Shi, Dongping
Jang, Hyejeong
Kim, Hyeong-Reh
Prunotto, Marco
Fridman, Rafael
author_sort Bonfil, R. Daniel
collection PubMed
description BACKGROUND: The Discoidin Domain Receptor 1 (DDR1) is one of the two members of a unique family of receptor tyrosine kinase receptors that signal in response to collagen, which has been implicated in cancer progression. Here, we examined the expression of DDR1 in prostate cancer (PCa), and assessed its potential value as a prognostic marker, as a function of grade, stage and other clinicopathologic parameters. METHODS: We investigated the association between the expression level and subcellular localization of DDR1 protein and PCa aggressiveness by immunohistochemistry, using tissue microarrays (TMAs) encompassing 200 cases of PCa with various Gleason scores (GS) and pathologic stages with matched normal tissue, and a highly specific monoclonal antibody. RESULTS: DDR1 was found to be localized in the membrane, cytoplasm, and nuclear compartments of both normal and cancerous prostate epithelial cells. Analyses of DDR1 expression in low GS (≤ 7[3 + 4]) vs high GS (≥ 7[4 + 3]) tissues showed no differences in nuclear or cytoplasmic DDR1in either cancerous or adjacent normal tissue cores. However, relative to normal-matched tissue, the percentage of cases with higher membranous DDR1 expression was significantly lower in high vs. low GS cancers. Although nuclear localization of DDR1 was consistently detected in our tissue samples and also in cultured human PCa and normal prostate-derived cell lines, its presence in that site could not be associated with disease aggressiveness. No associations between DDR1 expression and overall survival or biochemical recurrence were found in this cohort of patients. CONCLUSION: The data obtained through multivariate logistic regression model analysis suggest that the level of membranous DDR1 expression status may represent a potential biomarker of utility for better determination of PCa aggressiveness. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02206-1.
format Online
Article
Text
id pubmed-8456559
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84565592021-09-22 Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness Bonfil, R. Daniel Chen, Wei Vranic, Semir Sohail, Anjum Shi, Dongping Jang, Hyejeong Kim, Hyeong-Reh Prunotto, Marco Fridman, Rafael Cancer Cell Int Primary Research BACKGROUND: The Discoidin Domain Receptor 1 (DDR1) is one of the two members of a unique family of receptor tyrosine kinase receptors that signal in response to collagen, which has been implicated in cancer progression. Here, we examined the expression of DDR1 in prostate cancer (PCa), and assessed its potential value as a prognostic marker, as a function of grade, stage and other clinicopathologic parameters. METHODS: We investigated the association between the expression level and subcellular localization of DDR1 protein and PCa aggressiveness by immunohistochemistry, using tissue microarrays (TMAs) encompassing 200 cases of PCa with various Gleason scores (GS) and pathologic stages with matched normal tissue, and a highly specific monoclonal antibody. RESULTS: DDR1 was found to be localized in the membrane, cytoplasm, and nuclear compartments of both normal and cancerous prostate epithelial cells. Analyses of DDR1 expression in low GS (≤ 7[3 + 4]) vs high GS (≥ 7[4 + 3]) tissues showed no differences in nuclear or cytoplasmic DDR1in either cancerous or adjacent normal tissue cores. However, relative to normal-matched tissue, the percentage of cases with higher membranous DDR1 expression was significantly lower in high vs. low GS cancers. Although nuclear localization of DDR1 was consistently detected in our tissue samples and also in cultured human PCa and normal prostate-derived cell lines, its presence in that site could not be associated with disease aggressiveness. No associations between DDR1 expression and overall survival or biochemical recurrence were found in this cohort of patients. CONCLUSION: The data obtained through multivariate logistic regression model analysis suggest that the level of membranous DDR1 expression status may represent a potential biomarker of utility for better determination of PCa aggressiveness. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02206-1. BioMed Central 2021-09-21 /pmc/articles/PMC8456559/ /pubmed/34548097 http://dx.doi.org/10.1186/s12935-021-02206-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Primary Research
Bonfil, R. Daniel
Chen, Wei
Vranic, Semir
Sohail, Anjum
Shi, Dongping
Jang, Hyejeong
Kim, Hyeong-Reh
Prunotto, Marco
Fridman, Rafael
Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness
title Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness
title_full Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness
title_fullStr Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness
title_full_unstemmed Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness
title_short Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness
title_sort expression and subcellular localization of discoidin domain receptor 1 (ddr1) define prostate cancer aggressiveness
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456559/
https://www.ncbi.nlm.nih.gov/pubmed/34548097
http://dx.doi.org/10.1186/s12935-021-02206-1
work_keys_str_mv AT bonfilrdaniel expressionandsubcellularlocalizationofdiscoidindomainreceptor1ddr1defineprostatecanceraggressiveness
AT chenwei expressionandsubcellularlocalizationofdiscoidindomainreceptor1ddr1defineprostatecanceraggressiveness
AT vranicsemir expressionandsubcellularlocalizationofdiscoidindomainreceptor1ddr1defineprostatecanceraggressiveness
AT sohailanjum expressionandsubcellularlocalizationofdiscoidindomainreceptor1ddr1defineprostatecanceraggressiveness
AT shidongping expressionandsubcellularlocalizationofdiscoidindomainreceptor1ddr1defineprostatecanceraggressiveness
AT janghyejeong expressionandsubcellularlocalizationofdiscoidindomainreceptor1ddr1defineprostatecanceraggressiveness
AT kimhyeongreh expressionandsubcellularlocalizationofdiscoidindomainreceptor1ddr1defineprostatecanceraggressiveness
AT prunottomarco expressionandsubcellularlocalizationofdiscoidindomainreceptor1ddr1defineprostatecanceraggressiveness
AT fridmanrafael expressionandsubcellularlocalizationofdiscoidindomainreceptor1ddr1defineprostatecanceraggressiveness